Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024383628> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2024383628 endingPage "459" @default.
- W2024383628 startingPage "459" @default.
- W2024383628 abstract "A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase Regina P El Dib1, Gregory M Pastores21Department of Surgery, McMaster University, McMaster Institute of Urology, Hamilton, Ontario, Canada; 2Department of Neurology and Pediatrics, New York University School of Medicine, New York, NY, USAIntroduction: Mucopolysaccharidosis type VI (MPS VI, Maroteaux-Lamy syndrome) is an autosomal recessive lysosomal storage disorder, characterized primarily by skeletal dysplasia and joint contracture. It is caused by a deficiency of N-acetylgalactosamine-4-sulfatase (arylsulfatase B), for which a recombinant formulation (galsulfase) is available as replacement therapy. Objective: To evaluate the effectiveness and safety of galsulfase compared to placebo or no interventions, for treating MPS VI. We also considered studies evaluating different doses of galsulfase.Methods: A systematic review of the literature was conducted. A computerized electronic search in MEDLINE, EMBASE, CENTRAL, SciELO, and LILACS was carried on to identify any randomized trials that met our inclusion criteria.Results: Two studies were included in the review. Because the number of studies was small, our analysis probably did not find any statistically significant difference. Long-term follow-up will be required to ascertain full clinical benefit, on both event-free survival and quality of life measures.Conclusions: There is some evidence to support the use of galsulfase in the treatment of MPS VI; however due to the very low quantity of included studies we could not analyze it in an appropriate way. This review highlights the need for continued research into the use of enzyme replacement therapy for MPS VI.Keywords: mucopolysaccharidosis VI, Maroteaux-Lamy syndrome, galsulfase, naglazyme, systematic review" @default.
- W2024383628 created "2016-06-24" @default.
- W2024383628 creator A5017093187 @default.
- W2024383628 creator A5034907992 @default.
- W2024383628 date "2009-09-01" @default.
- W2024383628 modified "2023-09-27" @default.
- W2024383628 title "A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase" @default.
- W2024383628 cites W1554040650 @default.
- W2024383628 cites W1980579070 @default.
- W2024383628 cites W2033516257 @default.
- W2024383628 cites W2041158844 @default.
- W2024383628 cites W2068499319 @default.
- W2024383628 cites W2125435699 @default.
- W2024383628 cites W2126598189 @default.
- W2024383628 cites W2159320756 @default.
- W2024383628 cites W2166560053 @default.
- W2024383628 cites W2167018562 @default.
- W2024383628 cites W2168362005 @default.
- W2024383628 cites W2320816109 @default.
- W2024383628 cites W2614332825 @default.
- W2024383628 doi "https://doi.org/10.2147/btt.2009.3580" @default.
- W2024383628 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2763316" @default.
- W2024383628 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19851471" @default.
- W2024383628 hasPublicationYear "2009" @default.
- W2024383628 type Work @default.
- W2024383628 sameAs 2024383628 @default.
- W2024383628 citedByCount "4" @default.
- W2024383628 countsByYear W20243836282016 @default.
- W2024383628 countsByYear W20243836282021 @default.
- W2024383628 crossrefType "journal-article" @default.
- W2024383628 hasAuthorship W2024383628A5017093187 @default.
- W2024383628 hasAuthorship W2024383628A5034907992 @default.
- W2024383628 hasBestOaLocation W20243836281 @default.
- W2024383628 hasConcept C126322002 @default.
- W2024383628 hasConcept C177713679 @default.
- W2024383628 hasConcept C1862650 @default.
- W2024383628 hasConcept C187212893 @default.
- W2024383628 hasConcept C2779134260 @default.
- W2024383628 hasConcept C2779416428 @default.
- W2024383628 hasConcept C2779473830 @default.
- W2024383628 hasConcept C2779962280 @default.
- W2024383628 hasConcept C2779969927 @default.
- W2024383628 hasConcept C55493867 @default.
- W2024383628 hasConcept C71924100 @default.
- W2024383628 hasConcept C86803240 @default.
- W2024383628 hasConceptScore W2024383628C126322002 @default.
- W2024383628 hasConceptScore W2024383628C177713679 @default.
- W2024383628 hasConceptScore W2024383628C1862650 @default.
- W2024383628 hasConceptScore W2024383628C187212893 @default.
- W2024383628 hasConceptScore W2024383628C2779134260 @default.
- W2024383628 hasConceptScore W2024383628C2779416428 @default.
- W2024383628 hasConceptScore W2024383628C2779473830 @default.
- W2024383628 hasConceptScore W2024383628C2779962280 @default.
- W2024383628 hasConceptScore W2024383628C2779969927 @default.
- W2024383628 hasConceptScore W2024383628C55493867 @default.
- W2024383628 hasConceptScore W2024383628C71924100 @default.
- W2024383628 hasConceptScore W2024383628C86803240 @default.
- W2024383628 hasLocation W20243836281 @default.
- W2024383628 hasLocation W20243836282 @default.
- W2024383628 hasLocation W20243836283 @default.
- W2024383628 hasLocation W20243836284 @default.
- W2024383628 hasOpenAccess W2024383628 @default.
- W2024383628 hasPrimaryLocation W20243836281 @default.
- W2024383628 hasRelatedWork W1584581471 @default.
- W2024383628 hasRelatedWork W1953621380 @default.
- W2024383628 hasRelatedWork W2068499319 @default.
- W2024383628 hasRelatedWork W2884318611 @default.
- W2024383628 hasRelatedWork W2993504738 @default.
- W2024383628 hasRelatedWork W3039642561 @default.
- W2024383628 hasRelatedWork W3082276934 @default.
- W2024383628 hasRelatedWork W3149343681 @default.
- W2024383628 hasRelatedWork W4200201926 @default.
- W2024383628 hasRelatedWork W4240113361 @default.
- W2024383628 isParatext "false" @default.
- W2024383628 isRetracted "false" @default.
- W2024383628 magId "2024383628" @default.
- W2024383628 workType "article" @default.